Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
F1000Research|April 14, 2015
Further available immunization option to prevent pneumococcal diseaseIvo Vojtek, Bernard HoetTravel Medicine and Infectious Disease|September 2, 2008
Hepatitis B immunisation in travellers: poor risk perception and inadequate protectionJane N Zuckerman, Bernard HoetInternational Journal of Pediatric Otorhinolaryngology|August 14, 2017
Impact of pneumococcal conjugate vaccines on otitis media: A review of measurement and interpretation challengesIvo Vojtek, Marcus Nordgren, Bernard HoetBMC Pediatrics|February 4, 2010
Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?William P Hausdorff, Bernard Hoet, Lode SchuermanExpert Review of Vaccines|October 1, 2014
Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enoughWilliam P Hausdorff, Bernard Hoet, Richard A AdegbolaHuman Vaccines & Immunotherapeutics|July 27, 2016
Response to Wu et al. - Cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong KongLijoy Varghese, Bruce Mungall, Xu-Hao Zhang, et al.Vaccine|March 14, 2008
Long-term antibody persistence induced by a combined hepatitis A and B vaccine in children and adolescentsFrancisco Diaz-Mitoma, Barbara Law, Archana Subramanya, et al.Vaccine|December 29, 2018
Would immunization be the same without cross-reactivity?Ivo Vojtek, Philippe Buchy, T Mark Doherty, et al.Vaccine|November 14, 2006
Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adultsThomas Höhler, Gudrun Groeger-Bicanic, Bernard Hoet, et al.Clinical and Vaccine Immunology : CVI|June 26, 2009
Development and technical and clinical validation of a quantitative enzyme-linked immunosorbent assay for the detection of human antibodies to hepatitis B surface antigen in recipients of recombinant hepatitis B virus vaccinePierre Cambron, Jeanne-Marie Jacquet, Bernard Hoet, et al.Pageof 4